Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody: ocriplasmin, collagenase clostridium histolyticum | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 441 | 0.91 |
| pathways Reactome | 15 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 9592
Sealed predictions
- COL5A2 in dopamine neurons, braak+0.43 (p 0.244) → +0.00 (p 1.000)receipt 9599
Swarm cases
receipt 9599: COL5A2 in dopamine neurons, braak
- power
- full sample +0.32 (p 0.194, n 18), 95% CI -0.17 to +0.69. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.26 (p 0.298, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.29 (p 0.250, n 18). could be the mix.
- skeptic
- leave-one-out range +0.26 to +0.51, sign flips 0; without severely affected donors +0.32 (p 0.194, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for COL5A2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts